Skip to content
July 29, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Genomics and Precision Medicine
  • A New Chapter in Genomic Publishing: ASHG Announces Strategic Partnership with Oxford University Press
  • Genomics and Precision Medicine

A New Chapter in Genomic Publishing: ASHG Announces Strategic Partnership with Oxford University Press

Nana Wu July 29, 2026 7 minutes read
a-new-chapter-in-genomic-publishing-ashg-announces-strategic-partnership-with-oxford-university-press

ROCKVILLE, MD — In a move set to reshape the landscape of genetic research dissemination, the American Society of Human Genetics (ASHG) has officially announced that Oxford University Press (OUP) will become its new publishing partner. Effective January 2027, this transition marks a significant milestone for the world’s leading organization in human genetics, signaling a strategic pivot aimed at expanding the global reach, accessibility, and technological infrastructure of its two preeminent scholarly publications: The American Journal of Human Genetics (AJHG) and Human Genetics and Genomics Advances (HGG Advances).

The partnership represents more than a mere administrative change; it is a long-term commitment to the future of open science and the continued prestige of one of the most vital scientific disciplines of the 21st century.

Main Facts: The Core of the Agreement

Under the terms of the agreement, Oxford University Press will assume responsibility for the production, dissemination, and digital platform hosting of the ASHG’s journal portfolio. The transition is scheduled for completion by the start of the 2027 calendar year.

Crucially, the ASHG has emphasized that it will retain full editorial control over both publications. The society will continue to direct all peer-review processes, editorial policy, and the selection of editorial boards. This "editorial independence" model ensures that the transition to OUP does not compromise the rigorous scientific integrity that has defined the ASHG journals for decades.

The two journals covered under this agreement serve distinct but complementary roles:

  • The American Journal of Human Genetics (AJHG): The society’s flagship publication, which for over 75 years has acted as the primary record for foundational discoveries in the field.
  • Human Genetics and Genomics Advances (HGG Advances): The society’s fully open-access journal, designed for the rapid publication of diverse research findings that adhere to the highest standards of scientific reproducibility.

A Chronology of Scientific Publishing Excellence

To understand the weight of this announcement, one must look at the historical trajectory of the ASHG’s publishing efforts. Founded in 1948, the ASHG has spent three-quarters of a century fostering the growth of genetics from a niche biological field into a central pillar of modern medicine and biotechnology.

  • 1948: The ASHG is established to provide a forum for geneticists to share research and advocate for the field.
  • 1949: The first issue of AJHG is published, setting the standard for peer-reviewed research in human heredity.
  • Mid-20th Century: AJHG becomes the primary vehicle for reporting the mapping of the human genome and the development of clinical genetic diagnostics.
  • 2020: Recognizing the shift toward open-access publishing and the need for a faster, more flexible venue for modern genomic research, the society launches HGG Advances.
  • 2024: The ASHG concludes a comprehensive review of its publishing strategy, leading to the competitive selection of OUP as the ideal partner for the next generation of digital distribution.
  • January 2027: The official transition date when OUP will begin full operations for both journals.

Supporting Data: Why This Partnership Matters

The landscape of academic publishing has undergone a seismic shift over the last decade, moving away from traditional subscription models toward open access (OA) and data-rich digital platforms. The ASHG’s decision to partner with OUP is backed by several critical data points regarding the reach and impact of these journals.

The Power of the Flagship

AJHG consistently ranks among the highest-impact journals in the field of genetics. Its articles are frequently cited in clinical guidelines, public policy documents, and groundbreaking medical research. By partnering with OUP—the world’s largest university press with a portfolio of over 500 academic journals—the ASHG intends to leverage OUP’s sophisticated digital infrastructure to ensure that AJHG remains discoverable in an increasingly crowded information environment.

The Open Access Mandate

HGG Advances serves as the society’s primary mechanism for meeting the growing demand for Open Access. With the rise of mandates from major funding agencies (such as the NIH and the European Research Council) requiring that publicly funded research be made freely available, the partnership with OUP provides the necessary scalability to handle higher volumes of manuscript submissions while maintaining strict quality control. OUP’s expertise in managing hybrid and gold open-access journals provides the logistical support required to navigate the complex compliance landscape of modern global science.

Official Responses and Strategic Vision

The leadership at both the ASHG and OUP have expressed enthusiasm for the collaboration, highlighting the alignment of their organizational missions.

Susan A. Slaugenhaupt, PhD, President of the ASHG, noted that the society viewed this as an "exciting new chapter." She stated:

"OUP’s deep publishing expertise, global reach, and strong support for society journals will help us expand the visibility and impact of the research we publish while maintaining the editorial independence and scientific standards that are central to ASHG’s mission."

Dr. Slaugenhaupt’s emphasis on "editorial independence" is a key message to the scientific community, ensuring that researchers know that the rigorous, merit-based selection process for articles will remain firmly in the hands of the society’s elected editors and peer-reviewers.

Jennifer Paxton-Boyd, Publishing Director of Science at OUP, echoed these sentiments, noting the prestige associated with the ASHG portfolio:

"Oxford University Press is delighted to collaborate with ASHG to publish its prestigious journals. We look forward to working with the Society and editors to broaden the reach of their high-quality research, support the Society’s mission, and serve the global human genetics and genomics community."

For OUP, this partnership is a significant addition to their existing stable of learned society journals, reinforcing their position as a leading publisher for professional organizations.

Implications: The Future of Genomic Communication

The move to OUP will have several long-term implications for the 8,000-plus members of the ASHG and the broader scientific community.

1. Enhanced Discoverability and Digital Infrastructure

OUP’s platform is renowned for its advanced search capabilities and integration with global indexing databases. Authors publishing in AJHG and HGG Advances can expect their work to be more easily discoverable, which generally correlates with higher citation rates and broader societal impact.

2. Streamlined Submission Processes

The transition offers an opportunity for the ASHG to modernize its submission and peer-review management systems. By integrating with OUP’s standardized technological tools, the journals aim to reduce the "turnaround time" for researchers—an essential metric for scientists working in the fast-moving field of human genomics.

3. Strengthening the "Society-First" Model

In an era where large commercial publishers often dominate the academic landscape, the ASHG’s partnership with a university press (a non-profit entity) is a statement of values. It reinforces the importance of "society-led" publishing, where profits are reinvested into the community—supporting young investigators, public advocacy for genomic literacy, and the organization of the annual ASHG meeting.

4. Global Accessibility

Genomics is an increasingly global endeavor. By leveraging OUP’s international network and existing relationships with global academic institutions, the ASHG aims to improve access for researchers in low- and middle-income countries. This aligns with the society’s commitment to ensuring that the benefits of genomic research are distributed equitably across the globe.

Conclusion

As the fields of human genetics and genomics move toward a future defined by precision medicine and complex ethical considerations, the role of reliable, high-impact scientific journals has never been more critical. The partnership between the American Society of Human Genetics and Oxford University Press serves as a stabilizing force, ensuring that the foundational research of today becomes the clinical reality of tomorrow.

With a shared commitment to rigor, integrity, and the advancement of knowledge, this collaboration promises to bolster the influence of the ASHG journals, providing the global research community with the tools they need to unlock the mysteries of the human genome. As of January 2027, the scientific world will look to this new partnership to continue setting the gold standard for genomic publication.

About the Author

Nana Wu

Author

View All Posts

Post navigation

Previous: Beyond the Checkbook: Redefining Corporate Social Responsibility Through Gifts-in-Kind
Next: A Crossroads in Global Health: WHO Report Evaluates Progress Toward 2030 Goals for HIV, Hepatitis, and STIs

Related Stories

the-frontier-of-genetic-medicine-understanding-the-divide-between-in-vivo-and-ex-vivo-therapies
  • Genomics and Precision Medicine

The Frontier of Genetic Medicine: Understanding the Divide Between In Vivo and Ex Vivo Therapies

Azzam Bilal Chamdy July 26, 2026
navigating-the-future-of-genomics-insights-from-a-two-decade-industry-veteran
  • Genomics and Precision Medicine

Navigating the Future of Genomics: Insights from a Two-Decade Industry Veteran

Nila Kartika Wati July 26, 2026
a-genetic-shield-how-new-genomic-testing-is-revolutionizing-post-stroke-care
  • Genomics and Precision Medicine

A Genetic Shield: How New Genomic Testing is Revolutionizing Post-Stroke Care

Layla Zulfa July 26, 2026

Recent Posts

  • Vertex Pharmaceuticals Expands Beyond Cystic Fibrosis with Strategic AbCellera Partnership
  • The 340B Tug-of-War: CMS Proposes Major Reimbursement Overhaul for 2027
  • The Wisdom of the Tortoise: Unveiling the Depths of Kurmasana
  • Ibuprofen: Beyond Pain Relief – Unearthing Its Unexpected Anti-Cancer Potential
  • The Anatomy of Resilience: A Survivor’s Perspective on the Cancer Journey

Recent Comments

No comments to show.

Archives

  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

vertex-pharmaceuticals-expands-beyond-cystic-fibrosis-with-strategic-abcellera-partnership
  • Chemotherapy and Targeted Therapy

Vertex Pharmaceuticals Expands Beyond Cystic Fibrosis with Strategic AbCellera Partnership

Sagoh July 29, 2026
the-340b-tug-of-war-cms-proposes-major-reimbursement-overhaul-for-2027
  • Breast Cancer Legislation and Policy

The 340B Tug-of-War: CMS Proposes Major Reimbursement Overhaul for 2027

Suro Senen July 29, 2026
the-wisdom-of-the-tortoise-unveiling-the-depths-of-kurmasana
  • Integrative Oncology and Holistic Care

The Wisdom of the Tortoise: Unveiling the Depths of Kurmasana

Neng Nana July 29, 2026
ibuprofen-beyond-pain-relief-unearthing-its-unexpected-anti-cancer-potential
  • Medical Research and Clinical Trials

Ibuprofen: Beyond Pain Relief – Unearthing Its Unexpected Anti-Cancer Potential

Rifan Muazin July 29, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.